Research and innovation in Texas A&M University's biomedical engineering department often centers around clinical impact on ...
Engineered cells are a high-value genetic asset that is key to many fields, including biotechnology, medicine, aging, and ...
Morning Overview on MSN
AI-built proteins designed from scratch detect specific compounds
A team of researchers at the Korea Advanced Institute of Science and Technology (KAIST) has used artificial intelligence to ...
Agricultural biotechnology, or “agri-biotech,” uses science to make plants better. Think of it like giving crops special ...
Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...
Experts from the Physicians Committee for Responsible Medicine traveled to San Diego, California, to attend the 2026 Society of Toxicology Annual Meeting to advance our work accelerating the ...
Harvard's Wyss Institute and Emulate Bio say results from the AVATAR project could provide insights on how travel into deep ...
The synthetic biology market is being shaped by the growing use of engineered organisms in drug development, vaccine production, and gene therapies. The ability to manipulate DNA and create customized ...
According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected to grow to USD 23.53 billion in 2026, reaching an estimated USD 56.48 ...
Learn more about whether Relay Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ ...
Leslie Credle is a passionate social justice leader dedicated to reforming inequitable systems in housing and community support. As the Founder and Executive Director of Justice for Housing (J4H), she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results